Randomised clinical trials: Unusual designs

Perfusion

Volumn 17, Issue 11, 2004, Pages 416-421

  Ernst, Edzard ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Clinical research; Controlled clinical trial

Indexed keywords

EID: 17444401686     PISSN: 09350020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Mathews J. Introduction to randomized controlled trials. Edward Arnold, London 2000
2. Jadad A. Randomised controlled trials. BMJ Books, London 1998
3. Rabeneck L, Viscoli CM, Horwotz RI. Problems in the conduct and analysis of randomized clinical trials. Arch Intern Med 1992;152:507-512
4. Black N. Why we need observational studies to evaluate the effectiveness of Healthcare. Br Med J 1996;312:1215-1218
5. Park J, Park H-J, Ernst E. What's in a name? A systematic review of the nomenclature of Chinese medical formulae. Am J Chinese Med 2002;30:419-427
6. Roland M, Torgerson DJ. What are pragmatic trials? Br Med J 1998;31:285
7. Senn S. Cross-over trials in clinical research. John Wiley & Sons, Chichester 1993
8. Ernst E. Establishing efficacy in chronic stable conditions: are 'N = 1 study' designs or case series useful? Forsch Komplementärmed 1998;5(Suppl 1):128-130
9. Woods KL. Mega-trials and the management of acute infarction. Lancet 1995;346:611-614
10. Diggle G. Randomisation in controlled trials. Good Clin Pract J 1996;3:24-26
11. Balaam TN. Two-period design with t2 experimental units. Biometrics 1968;24:61-73
12. Baskerville JC, Toogood JH, Mazza J, Jennings B. Clinical trials designed to evaluate therapeutic preferences. Stat Med 1984;3:44-55
13. Silverman WA, Altman DG. Patients' preferences and randomised trials. Lancet 1996;347:171-174
14. Brewin CR, Bradley C. Patient preferences and randomised clinical trials. Br Med J 1989;299:684-685
15. Olschewski M, Scheurlen H. Comprehensive cohort study. Methods Int Med 1985;24:131-134
16. Wennberg JE, Barry MJ, Fowler FJ, Mulley A. Outcomes research, PORTs, and healthcare reform. Ann NY Acad Sciences 1993;703:52-62
17. Zelen M. A new design for randomised trials. New Engl J Med 1979;300:1242-1245
18. Chang RW, Falconer J, Stulberg SD, Arnold WJ, Dyer AR. Prerandomization: an alternative to classic randomisation. J Bone Joint Surg Am 1990;72:1451-1455
19. Zelen M. Randomized consent designs for clinical trials: an update. Stat Med 1990;9:1242-1245
20. Hogel J, Walach H, Gaus W. Change-to-open-label design: proposal and discussion of a new design for clinical parallel-group double-masked trials. Arzneim-Forsch/Drug Res 1994;44:97-99
21. Walach H. Das »Change-to-open-label« (COLA)-Design: Anpassung und Veränderung des Parallelgruppen-Blinddesigns für die klinische Forschung. Z Klin Psychol Psychopathol Psychother 1994;23:213-218
22. Ernst E, Resch KL. The »optional crossover design« for randomized controlled trials. Fundam Clin Pharmacol 1995;9:508-511
23. Wei LJ, Durham S. The randomized play-the-winner rule in medical trials. J Am Stat Assoc 1978;73:840-843
24. Rosenberger WF. Randomized play the winner clinical trials. Review and recommendations. Control Clin Trials 1999;20:328-342
25. Zelen M. Play the winner rule and the controlled clinical trial. J Am Stat Ass 1969;64:131-146
26. Korn EL, Baumrind S. Randomised clinical trials with clinician-preferred treatment. Lancet 1991;337:149-152
27. Capelleri JC, Trochim WMK. An illustrative statistical analysis of cut-off based randomized clinical trials. J Clin Epidemiol 1994;47:261-270